Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling.

Abstract:

:Infiltrating macrophages are a key component of inflammation during tumorigenesis, but the direct evidence of such linkage remains unclear. We report here that persistent coculturing of immortalized prostate epithelial cells with macrophages, without adding any carcinogens, induces prostate tumorigenesis and that induction involves the alteration of signaling of macrophage androgen receptor (AR)-inflammatory chemokine CCL4-STAT3 activation as well as epithelial-to-mesenchymal transition and downregulation of p53/PTEN tumor suppressors. In vivo studies further showed that PTEN(+/-) mice lacking macrophage AR developed far fewer prostatic intraepithelial neoplasia (PIN) lesions, supporting an in vivo role for macrophage AR during prostate tumorigenesis. CCL4-neutralizing antibody effectively blocked macrophage-induced prostate tumorigenic signaling and targeting AR via an AR-degradation enhancer, ASC-J9, reduced CCL4 expression, and xenografted tumor growth in vivo. Importantly, CCL4 upregulation was associated with increased Snail expression and downregulation of p53/PTEN in high-grade PIN and prostate cancer. Together, our results identify the AR-CCL4-STAT3 axis as key regulators during prostate tumor initiation and highlight the important roles of infiltrating macrophages and inflammatory cytokines for the prostate tumorigenesis.

journal_name

Cancer Res

journal_title

Cancer research

authors

Fang LY,Izumi K,Lai KP,Liang L,Li L,Miyamoto H,Lin WJ,Chang C

doi

10.1158/0008-5472.CAN-12-3228

subject

Has Abstract

pub_date

2013-09-15 00:00:00

pages

5633-46

issue

18

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-12-3228

journal_volume

73

pub_type

杂志文章
  • Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules.

    abstract::Insulin-like growth factor (IGF) I has important growth regulatory functions in normal growth and development. IGF-I is also a mitogen for a number of cancer cell lines; however, its autocrine effect has not been well established. In this study, the expression of IGF-I, its receptor, and its major serum-binding protei...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lee TC,Zhang Y,Aston C,Hintz R,Jagirdar J,Perle MA,Burt M,Rom WN

    更新日期:1993-06-15 00:00:00

  • Reduction of O6-alkylguanine-DNA alkyltransferase activity in HeLa cells treated with O6-alkylguanines.

    abstract::Exposure of HeLa cells to 0.2 mM O6-methylguanine for 4 h or longer led to a 70-80% loss in the activity of the DNA-repair protein, O6-alkylguanine-DNA alkyltransferase. The decline in alkyltransferase activity brought about by O6-methylguanine was reversible on removing the base but at least 48 h were required for co...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dolan ME,Morimoto K,Pegg AE

    更新日期:1985-12-01 00:00:00

  • Optimal ratios of biliary glycoprotein isoforms required for inhibition of colonic tumor cell growth.

    abstract::Rodent biliary glycoprotein (Bgp), also known as C-CAM, has recently been shown to function as a tumor suppressor in colon, prostate, and bladder cancers. This glycoprotein is a member of the carcinoembryonic antigen family and is one of the only proteins in this family to encode either a long (71-73 amino acids) or s...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Turbide C,Kunath T,Daniels E,Beauchemin N

    更新日期:1997-07-01 00:00:00

  • Pharmacology studies of 1-beta-D-arabinofuranosylcytosine in pediatric patients with leukemia and lymphoma after a biochemically optimal regimen of loading bolus plus continuous infusion of the drug.

    abstract::In an attempt to maximize the therapeutic index and to overcome the large variations in 1-beta-D-arabinofuranosylcytosine (ara-C) plasma levels and host toxicities that have been documented with standard HDara-C regimens (3 g/m2 over 3 h every 12 h x 8 or x12 doses), pediatric patients with acute lymphocytic leukemia ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Avramis VI,Weinberg KI,Sato JK,Lenarsky C,Willoughby ML,Coates TD,Ozkaynak MF,Parkman R

    更新日期:1989-01-01 00:00:00

  • Ductal access for prevention and therapy of mammary tumors.

    abstract::In cancer patients and in those at high risk, systemic exposure to agents for therapy or prevention is accompanied by undesirable side effects. We hypothesized that it is possible to prevent and treat breast cancer by introducing anticancer agents into the mammary ductal network. Here, we show the efficacy of intraduc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-4329

    authors: Murata S,Kominsky SL,Vali M,Zhang Z,Garrett-Mayer E,Korz D,Huso D,Baker SD,Barber J,Jaffee E,Reilly RT,Sukumar S

    更新日期:2006-01-15 00:00:00

  • Combined modality therapy with bleomycin, hyperthermia, and radiation.

    abstract::In an attempt to develop better combination therapies for use with local radiation, the interaction between bleomycin and hyperthermia +/- radiation was studied in the FSaIIC tumor system. In cells exposed in vitro to bleomycin at 37 degrees C and at pH 7.40, the drug was substantially more toxic toward normally oxyge...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Teicher BA,Herman TS,Holden SA

    更新日期:1988-11-15 00:00:00

  • RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN.

    abstract::Therapeutic inhibition of mammalian target of rapamycin (mTOR) in cancer is complicated by the existence of a negative feedback loop linking mTOR to the phosphatidylinositol 3-kinase (PI3K)-Akt pathway. Thus, mTOR inhibition by rapamycin or TSC1/2 results in increased PI3K-Akt activation. The death domain kinase recep...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-0474

    authors: Park S,Zhao D,Hatanpaa KJ,Mickey BE,Saha D,Boothman DA,Story MD,Wong ET,Burma S,Georgescu MM,Rangnekar VM,Chauncey SS,Habib AA

    更新日期:2009-05-15 00:00:00

  • Experimental radiation therapy and apparent radioresistance of autochthonous tumors subcutaneously induced with 3-methylcholanthrene in mice.

    abstract::The radiation response of autochthonous tumors induced by s.c. injection of 3-methylcholanthrene in ICR/JCL mice was studied. The tumors were mostly fibrosarcomas and grew with an average volume-doubling time of 2.6 days, independently of the time tumor appearance or dose of the chemical used. The tumors were locally ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tanooka H,Hoshino H,Tanaka K,Nagase M

    更新日期:1980-07-01 00:00:00

  • The suppression of drug-induced apoptosis by activation of v-ABL protein tyrosine kinase.

    abstract::Cells with a temperature-sensitive mutant of the v-abl oncoprotein (IC.DP) were treated with the anticancer drugs melphalan or hydroxyurea. At the restrictive temperature for v-ABL protein tyrosine kinase activity, drug-treated IC.DP cells died by apoptosis. In contrast, apoptotic cell death induced by either drug was...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chapman RS,Whetton AD,Dive C

    更新日期:1994-10-01 00:00:00

  • Metabolism and biological activity of 5'-deoxy-5-fluorouridine, a novel fluoropyrimidine.

    abstract::5'-Deoxy-5-fluorouridine (5'-dFUrd; Roche 21-9738) is a recently synthesized antineoplastic agent with therapeutic potential. The sensitivity of Ehrlich ascites tumor cells in CF-1 mice to 5'-dFUrd, as well as to 5-fluorouridine, was established. 5'-dFUrd was a more effective antitumor agent and was less toxic over a ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Armstrong RD,Diasio RB

    更新日期:1980-09-01 00:00:00

  • Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods.

    abstract::Biochemical quantitation of estrogen receptors has been used to predict prognosis in breast cancer. Immunocytochemical analysis of estrogen receptors correlates with biochemical analysis but has very few follow-up studies in the literature to validate it as a prognostic indicator. 257 patients were followed for up to ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kinsel LB,Szabo E,Greene GL,Konrath J,Leight GS,McCarty KS Jr

    更新日期:1989-02-15 00:00:00

  • Limited capability of regional lymph nodes to eradicate metastatic cancer cells.

    abstract::The capacity of lymph nodes to eradicate cancer is a controversial issue. The purpose of this study was to determine the interplay between tumor growth and host resistance at early stages of lymph node metastasis. A metastasis model was made in the rat mesenteric lymph node, and migration of cancer cells was visualize...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-1182

    authors: Nagata H,Arai T,Soejima Y,Suzuki H,Ishii H,Hibi T

    更新日期:2004-11-15 00:00:00

  • Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.

    abstract::Tumor infiltrating lymphocytes (TIL) were isolated from 22 tumors obtained from 15 patients with metastatic melanoma. In 18 of the 22 tumors, a substantial number of lymphocytes was isolated with an average lymphoid cell:tumor cell ratio of 1.26. The TIL were predominantly cytotoxic/suppressor T-lymphocytes with an av...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Itoh K,Tilden AB,Balch CM

    更新日期:1986-06-01 00:00:00

  • SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.

    abstract::Activation of the matrix metalloproteinase 2 (MMP-2) has been shown to play a major role in the proteolysis of extracellular matrix (ECM) associated with tumor invasion. Although the precise mechanism of this activation remains elusive, levels of the membrane type 1-MMP (MT1-MMP) at the cell surface and of the tissue ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gilles C,Bassuk JA,Pulyaeva H,Sage EH,Foidart JM,Thompson EW

    更新日期:1998-12-01 00:00:00

  • Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors.

    abstract::It is fairly well accepted that the presence of estrogen receptor (ER) and progesterone receptor (PgR) identifies breast cancer patients with a lower risk of relapse and better overall survival. But patients with discordant receptors, the ER+/PgR- phenotype, are often intermediate in clinical response. We focused upon...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fuqua SA,Fitzgerald SD,Allred DC,Elledge RM,Nawaz Z,McDonnell DP,O'Malley BW,Greene GL,McGuire WL

    更新日期:1992-01-15 00:00:00

  • Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules.

    abstract::There is considerable evidence that sphingosine kinases play a key role in cancer progression, which might involve positive selection of cancer cells that have been provided with a survival and growth advantage as a consequence of overexpression of the enzyme. Therefore, inhibitors of sphingosine kinase represent a no...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-11-2364

    authors: Pyne S,Bittman R,Pyne NJ

    更新日期:2011-11-01 00:00:00

  • Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice.

    abstract::Protein kinase Cepsilon (PKCepsilon), a Ca(2+)-independent, phospholipid-dependent serine/threonine kinase, is among the PKC isoforms expressed in mouse epidermis. We reported that FVB/N transgenic mice that overexpress ( approximately 18-fold) PKCepsilon protein in basal epidermal cells and cells of the hair follicle...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wheeler DL,Ness KJ,Oberley TD,Verma AK

    更新日期:2003-10-01 00:00:00

  • Cancer Cell-Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma.

    abstract::The prognosis for pancreatic ductal adenocarcinoma (PDAC) remains poor despite decades of effort. The abundant extracellular matrix (ECM) in PDAC comprises a major fraction of the tumor mass and plays various roles in promoting resistance to therapies. However, nonselective depletion of ECM has led to poor patient out...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-2578

    authors: Tian C,Öhlund D,Rickelt S,Lidström T,Huang Y,Hao L,Zhao RT,Franklin O,Bhatia SN,Tuveson DA,Hynes RO

    更新日期:2020-04-01 00:00:00

  • Effect of caffeine on induction of endogenous type C virus in mouse cells in vitro.

    abstract::The effect of caffeine on the expression of murine endogenous virus in mouse cells induced by radiation and chemicals was studied. Postirradiation treatment of K-BALB cells with caffeine enhanced cell killing as well as the induction of xenotropic virus after ultraviolet light irradiation. The degree of enhancement fo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Niwa O,Sugahara T

    更新日期:1981-08-01 00:00:00

  • Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran- 5,6-dione), a novel DNA repair inhibitor.

    abstract::3,4-Dihydro-2,2-dimethyl-2H-naptho[1,2,-b]pyran-5,6-dione (beta-lapachone) is a novel DNA repair inhibitor. It was tested for synergistic X-ray-induced lethality in combination with several halogenated pyrimidine radiosensitizers. Logarithmic-phase growing human epidermoid laryngeal carcinoma (HEp-2) cells were allowe...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Boothman DA,Greer S,Pardee AB

    更新日期:1987-10-15 00:00:00

  • Loss of Cdk2 and cyclin A2 impairs cell proliferation and tumorigenesis.

    abstract::Cell-cycle inhibition has yet to offer a generally effective approach to cancer treatment, but a full evaluation of different combinations of cell-cycle inhibitors has not been evaluated. Cyclin A2, a core component of the cell cycle, is often aberrantly expressed in cancer where it may impact cell proliferation. In t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-3440

    authors: Gopinathan L,Tan SL,Padmakumar VC,Coppola V,Tessarollo L,Kaldis P

    更新日期:2014-07-15 00:00:00

  • A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer.

    abstract::Methyl-CpG binding domain (MBD) proteins have been shown to couple DNA methylation to transcriptional repression. This biological property suggests a role for MBD proteins in the silencing of tumor suppressor genes that are hypermethylated at their promoter CpG islands in cancer cells. Despite the demonstration of the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-1932

    authors: Lopez-Serra L,Ballestar E,Fraga MF,Alaminos M,Setien F,Esteller M

    更新日期:2006-09-01 00:00:00

  • Prospective correlative chemosensitivity testing in high-dose intraarterial chemotherapy for liver metastases.

    abstract::Clinical response of liver metastases treated by high-dose intraarterial chemotherapy (HDIAC) delivered via the hepatic artery was predicted by a modification of the human tumor colony-forming assay (HTCFA) originally described by Hamburger and Salmon [Science (Wash. DC), 197:461-463, 1977. In a first set of experimen...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Link KH,Aigner KR,Kuehn W,Schwemmle K,Kern DH

    更新日期:1986-09-01 00:00:00

  • Mechanism of cultured endothelial injury induced by lymphokine-activated killer cells.

    abstract::A new form of therapy of experimental tumors, utilizing lymphokine-activated killer (LAK) cells and high doses of interleukin 2, has recently been applied in the treatment of human neoplasms. Severe side effects, suggestive of a diffuse vascular injury of unknown etiology, have prevented a more widespread application ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kotasek D,Vercellotti GM,Ochoa AC,Bach FH,White JG,Jacob HS

    更新日期:1988-10-01 00:00:00

  • BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization.

    abstract::SWI/SNF chromatin remodeling complexes regulate critical cellular processes, including cell-cycle control, programmed cell death, differentiation, genomic instability, and DNA repair. Inactivation of this class of chromatin remodeling complex has been associated with a variety of malignancies, including lung, ovarian,...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-0061

    authors: Orvis T,Hepperla A,Walter V,Song S,Simon J,Parker J,Wilkerson MD,Desai N,Major MB,Hayes DN,Davis IJ,Weissman B

    更新日期:2014-11-15 00:00:00

  • Melanogenesis in human melanomas.

    abstract::A number of biochemical aspects of melanogenesis were studied in 15 variously melanized human melanomas. The tryosinase activity was correlated with the degree of melanoma varied from 3,667 to 46,183 tryosinase units, in partially melanotic melanoma it varied from 14 to 75 tryrosinase units. The subcellular distributi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chen YM,Chavin W

    更新日期:1975-03-01 00:00:00

  • FGFR1 Induces Glioblastoma Radioresistance through the PLCγ/Hif1α Pathway.

    abstract::FGF2 signaling in glioblastoma induces resistance to radiotherapy, so targeting FGF2/FGFR pathways might offer a rational strategy for tumor radiosensitization. To investigate this possibility, we evaluated a specific role for FGFR1 in glioblastoma radioresistance as modeled by U87 and LN18 glioblastomas in mouse xeno...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-2058

    authors: Gouazé-Andersson V,Delmas C,Taurand M,Martinez-Gala J,Evrard S,Mazoyer S,Toulas C,Cohen-Jonathan-Moyal E

    更新日期:2016-05-15 00:00:00

  • Role of substrate depletion in the inhibition of thymidylate biosynthesis by the dihydrofolate reductase inhibitor trimetrexate in cultured hepatoma cells.

    abstract::The effects of the lipid-soluble dihydrofolate reductase inhibitor, trimetrexate, on the inhibition of thymidylate biosynthesis as a result of perturbation in cellular folate pools in H35 hepatoma cells in vitro has been investigated. Exposure of the cultures to increasing concentrations of trimetrexate between 2 and ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rhee MS,Balinska M,Bunni M,Priest DG,Maley GF,Maley F,Galivan J

    更新日期:1990-07-01 00:00:00

  • The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors.

    abstract::Available evidence suggests that, among hematological malignancies, p53 is most often mutated in Burkitt's lymphoma (BL). However, much of the published data is based on cell lines. We have, therefore, analyzed BL biopsies to determine more accurately the frequency and pattern of p53 mutations in primary tumors and to...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bhatia KG,Gutiérrez MI,Huppi K,Siwarski D,Magrath IT

    更新日期:1992-08-01 00:00:00

  • Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.

    abstract::Resistance to the cytotoxic effects of daunomycin and Adriamycin (ADR) in sublines of Ehrlich ascites and P388 mouse tumors has been demonstrated to be due to reduced cellular accumulation and retention of drug. In this study, the effect of the calmodulin inhibitor trifluoperazine on the cellular accumulation, retenti...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ganapathi R,Grabowski D

    更新日期:1983-08-01 00:00:00